Accesso libero

Cyclin-dependent kinase (CDK) 4/6 inhibitors in oncology

Evangelos Karamitrousis

Evangelos Karamitrousis

Department of Medical Oncology, Democritus University of ThraceAlexandroupolis, Greece
Cerca questo autore su
Sciendo|Google Scholar
Karamitrousis, Evangelos
, 
Michalis Liontos

Michalis Liontos

Department of Clinical Therapeutics, Alexandra HospitalAthens, Greece
Cerca questo autore su
Sciendo|Google Scholar
Liontos, Michalis
 e 
Nikolaos Tsoukalas

Nikolaos Tsoukalas

Department of Oncology, 401 General Military HospitalAthens, Greece
Cerca questo autore su
Sciendo|Google Scholar
Tsoukalas, Nikolaos
  
05 apr 2020
Cyclin-dependent kinase (CDK) 4/6 inhibitors in oncology's Cover Image
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Cita
Scarica la copertina
Categoria dell'articolo: Editorial
Pubblicato online: 05 apr 2020
Pagine: 1 - 1
DOI: https://doi.org/10.2478/fco-2019-0008
Parole chiave
© 2019 Evangelos Karamitrousis et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Karamitrousis, Evangelos
Department of Medical Oncology, Democritus University of ThraceAlexandroupolis, Greece
Liontos, Michalis
Department of Clinical Therapeutics, Alexandra HospitalAthens, Greece
Tsoukalas, Nikolaos
Department of Oncology, 401 General Military HospitalAthens, Greece
Lingua:
Inglese
Frequenza di pubblicazione:
2 volte all'anno
Argomenti della rivista:
Medicina, Medicina clinica, Medicina interna, Ematologia, Oncologia
Feed RSS della rivista